Editorial
Accepted on 20 Feb 2025
Methodological evolution of external Comparator Studies
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1579171
Type at least 3 characters
76 articles
Articles
Original Research
Accepted on 17 Feb 2025
Developing Decision Support Algorithm of Hypertension Medications for Use in a Digital Therapeutic System
in Cardiovascular Drug Safety
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1476998
Perspective
Published on 13 Feb 2025
Implementing tokenization in clinical research to expand real-world insights
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1519307
- 203 views
Review
Published on 17 Jan 2025
Integrating environmental effects in the benefit-risk assessment of therapeutic products: a proposal and example for sustainable health and healthcare
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1519142
- 371 views
Original Research
Published on 16 Jan 2025
The safety and efficacy of neutral electrolyzed water solution for wound irrigation: post-market clinical follow-up study
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1402684
- 474 views
Original Research
Published on 06 Jan 2025
Detection of nontoxic BoNT/A levels in post-facial Botox injection breastmilk
in Maternal-Fetal Medicine
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1480515
- 449 views
Review
Published on 18 Dec 2024
Important tool in our rare disease toolbox: hybrid retrospective-prospective natural history studies serve well as external comparators for rare disease studies
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1418050
- 718 views
Original Research
Published on 06 Dec 2024
Influence of differential source patterns in the detection of signals of disproportionate reporting for PARP inhibitors
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1497116
- 589 views
Mini Review
Published on 13 Nov 2024
Integrating electronic health records with other data sources for postmarket drug safety signal identification: a review
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1428831
- 591 views
Editorial
Published on 13 Nov 2024
Editorial: AI/ML in pharmacovigilance and pharmacoepidemiology
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1517365
- 693 views
Perspective
Published on 30 Oct 2024
External comparator studies and the joint application of the estimand and target trial emulation frameworks
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1409102
- 778 views
Opinion
Published on 18 Sep 2024
Achieving synchrony: bridging the gap between pharmaceutical companies and regulators on safety labeling updates
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1477516
- 1,134 views
Original Research
Published on 17 Sep 2024
Demonstrating the principal mechanism of action of medical devices intended for vaginal use on reconstructed human vaginal epithelium: the case of two hyaluronic acid-containing devices
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1445519
- 671 views
Original Research
Published on 16 Aug 2024
Exploring the scientific underpinnings of investigating safety signals: analytical insights in deciphering drug safety evidence
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1445998
- 1,571 views
- 1 citation
Original Research
Published on 12 Aug 2024
Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group”
in Vaccine Safety and Regulation
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1363086
- 1,373 views
Original Research
Published on 19 Jul 2024
Measurement error and bias in real-world oncology endpoints when constructing external control arms
in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2024.1423493
- 2,661 views